Meridian Bioscience ROA 2006-2020 | VIVO

Current and historical return on assets (ROA) values for Meridian Bioscience (VIVO) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Meridian Bioscience ROA for the three months ending March 31, 2020 was 8.13%.
Meridian Bioscience ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2020-03-31 $0.02B $0.32B 6.44%
2019-12-31 $0.02B $0.34B 6.13%
2019-09-30 $0.02B $0.33B 8.34%
2019-06-30 $0.03B $0.32B 9.29%
2019-03-31 $0.03B $0.25B 10.70%
2018-12-31 $0.03B $0.25B 9.90%
2018-09-30 $0.02B $0.25B 9.09%
2018-06-30 $0.02B $0.25B 9.50%
2018-03-31 $0.02B $0.26B 6.79%
2017-12-31 $0.02B $0.25B 8.41%
2017-09-30 $0.02B $0.25B 8.43%
2017-06-30 $0.02B $0.25B 8.01%
2017-03-31 $0.03B $0.25B 11.50%
2016-12-31 $0.03B $0.25B 11.43%
2016-09-30 $0.03B $0.25B 13.46%
2016-06-30 $0.04B $0.26B 15.87%
2016-03-31 $0.04B $0.26B 17.37%
2015-12-31 $0.04B $0.19B 19.83%
2015-09-30 $0.04B $0.18B 19.53%
2015-06-30 $0.04B $0.18B 19.69%
2015-03-31 $0.04B $0.18B 19.69%
2014-12-31 $0.04B $0.18B 19.69%
2014-09-30 $0.03B $0.18B 19.18%
2014-06-30 $0.04B $0.18B 19.75%
2014-03-31 $0.04B $0.18B 20.54%
2013-12-31 $0.04B $0.18B 20.90%
2013-09-30 $0.04B $0.18B 22.06%
2013-06-30 $0.04B $0.17B 22.60%
2013-03-31 $0.04B $0.17B 22.40%
2012-12-31 $0.04B $0.16B 22.68%
2012-09-30 $0.04B $0.16B 22.12%
2012-06-30 $0.03B $0.16B 21.05%
2012-03-31 $0.03B $0.16B 19.81%
2011-12-31 $0.03B $0.16B 17.92%
2011-09-30 $0.03B $0.16B 17.25%
2011-06-30 $0.03B $0.16B 15.97%
2011-03-31 $0.02B $0.16B 15.56%
2010-12-31 $0.02B $0.16B 15.03%
2010-09-30 $0.03B $0.16B 17.02%
2010-06-30 $0.03B $0.15B 19.61%
2010-03-31 $0.03B $0.15B 21.60%
2009-12-31 $0.03B $0.16B 22.48%
2009-09-30 $0.03B $0.16B 22.15%
2009-06-30 $0.03B $0.15B 21.84%
2009-03-31 $0.03B $0.15B 21.42%
2008-12-31 $0.03B $0.15B 21.60%
2008-09-30 $0.03B $0.15B 21.31%
2008-06-30 $0.03B $0.14B 20.36%
2008-03-31 $0.03B $0.14B 21.68%
2007-12-31 $0.03B $0.14B 21.71%
2007-09-30 $0.03B $0.13B 21.47%
2007-06-30 $0.03B $0.13B 21.18%
2007-03-31 $0.02B $0.12B 18.33%
2006-12-31 $0.02B $0.12B 17.95%
2006-09-30 $0.02B $0.12B 16.63%
2006-06-30 $0.02B $0.12B 16.11%
2006-03-31 $0.02B $0.11B 15.50%
2005-12-31 $0.01B $0.11B 14.62%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.828B $0.201B
Meridian Bioscience, Inc. is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and biopharmaceutical enabling technologies that help deliver answers. Its products provide accuracy, simplicity and speed for the early diagnosis and treatment of common medical conditions, such as C. difficile, H. pylori, foodborne diseases and respiratory infections. In addition, the company develops and manufactures a variety of biological and non-biological materials used in proficiency testing programs. Meridian diagnostic products are used outside of the human body and require little or no special equipment. Meridian Bioscience designs their products to enhance the well-being of the patient-while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal infections, serology, parasitology and fungal disease diagnosis.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $179.231B 33.63
Medtronic (MDT) Ireland $134.197B 21.80
Stryker (SYK) United States $71.795B 27.84
Boston Scientific (BSX) United States $55.753B 32.21
Lonza Group Ag (LZAGY) Switzerland $46.856B 0.00
Baxter (BAX) United States $40.868B 24.99
Zimmer Biomet Holdings (ZBH) United States $28.859B 23.95
Terumo (TRUMY) Japan $28.725B 36.72
EssilorLuxottica Societe Anonyme (ESLOY) France $28.171B 0.00
ResMed (RMD) United States $25.062B 36.39
Sunny Optical Technology (SNPTF) China $20.566B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $18.308B 0.00
Bio-Rad Laboratories (BIO) United States $15.555B 70.35
Insulet (PODD) United States $13.736B 604.81
Shandong Weigao Medical Polymer (SHWGF) China $12.315B 0.00
Quidel (QDEL) United States $11.442B 60.61
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
GN STORE NORD (GNNDY) Denmark $8.157B 41.58
William Demant Holdings (WILYY) Denmark $7.457B 0.00
Perrigo (PRGO) Ireland $6.885B 11.81
Hill-Rom Holdings (HRC) United States $6.336B 15.72
Canopy Growth (CGC) Canada $6.168B 0.00
Neogen (NEOG) United States $4.337B 72.47
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.204B 0.00
Haemonetics (HAE) United States $4.045B 26.95
Envista Holdings (NVST) United States $3.725B 25.40
ICU Medical (ICUI) United States $3.702B 27.01
Abcam (ABCZY) $3.462B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.396B 0.00
Agios Pharmaceuticals (AGIO) United States $2.988B 0.00
NuVasive (NUVA) United States $2.753B 38.36
National Vision Holdings (EYE) United States $2.673B 416.25
TG Therapeutics (TGTX) United States $2.314B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.945B 179.15
AtriCure (ATRC) United States $1.911B 0.00
MacroGenics (MGNX) United States $1.484B 0.00
NanoString Technologies (NSTG) United States $1.330B 0.00
Aphria (APHA) Canada $1.287B 0.00
Aurora Cannabis (ACB) Canada $1.186B 0.00
Cerus (CERS) United States $1.173B 0.00
Cardiovascular Systems (CSII) United States $1.097B 0.00
InMode (INMD) Israel $1.016B 25.62
Quanterix (QTRX) United States $0.942B 0.00
PetIQ (PETQ) United States $0.895B 25.85
Lantheus Holdings (LNTH) United States $0.888B 12.31
OraSure Technologies (OSUR) United States $0.872B 0.00
Phibro Animal Health (PAHC) United States $0.825B 16.45
Owens & Minor (OMI) United States $0.813B 18.21
Vapotherm (VAPO) United States $0.781B 0.00
Omeros (OMER) United States $0.770B 0.00
BioLife Solutions (BLFS) United States $0.671B 350.33
Surmodics (SRDX) United States $0.650B 71.25
Eagle Pharmaceuticals (EGRX) United States $0.643B 46.08
VAREX IMAGING (VREX) United States $0.640B 15.90
LeMaitre Vascular (LMAT) United States $0.599B 36.62
Zynex (ZYXI) United States $0.591B 51.64
Cytosorbents (CTSO) United States $0.412B 0.00
Viemed Healthcare (VMD) United States $0.393B 14.04
Neptune Wellness Solutions (NEPT) Canada $0.325B 0.00
HEXO (HEXO) $0.319B 0.00
Utah Medical Products (UTMD) United States $0.294B 25.22
InfuSystems Holdings (INFU) United States $0.278B 154.11
Organigram Holdings (OGI) Canada $0.223B 0.00
Chimerix (CMRX) United States $0.211B 0.00
Female Health (VERU) United States $0.208B 0.00
Exagen (XGN) United States $0.179B 0.00
Bovie Medical (APYX) United States $0.171B 0.00
Surface Oncology (SURF) United States $0.170B 0.00
Fonar (FONR) United States $0.166B 14.75
Wound Management Technologies (SMTI) United States $0.153B 0.00
Liberty Health Sciences (LHSIF) Canada $0.128B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.123B 0.00
Evolus (EOLS) United States $0.118B 0.00
Rockwell Medical (RMTI) United States $0.115B 0.00
Chembio Diagnostics (CEMI) United States $0.111B 0.00
Capricor Therapeutics (CAPR) United States $0.093B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
MTech Acquisition (KERN) United States $0.087B 0.00
Nephros (NEPH) United States $0.071B 0.00
United-Guardian (UG) United States $0.069B 15.58
Brainsway (BWAY) Israel $0.067B 0.00
Trinity Biotech (TRIB) Ireland $0.063B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
Akers Biosciences Inc (AKER) United States $0.037B 0.00
GUARDION HEALTH (GHSI) United States $0.035B 0.00
FSD PHARMA INC (HUGE) Canada $0.027B 0.00
NF Energy Saving (BIMI) China $0.023B 0.00
Myomo (MYO) United States $0.011B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Senestech (SNES) United States $0.007B 0.00